ALISON AVALLONE: Open Payments
NPI 1134726540 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$321 in 19 payments from 11 companies in 2025. Trend: 2023 $342 · 2024 $979 · 2025 $321
Food & beverage: $301Education: $20
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $63 |
| ABBVIE INC. | 3 | $49 |
| Exact Sciences Corporation | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Boston Scientific Corporation | 1 | $22 |
| Lilly USA, LLC | 1 | $18 |
| Amgen Inc. | 1 | $17 |
| Medicure Pharma Inc. | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: Cologuard Collection Kit, UBRELVY, Rybelsus, Kerendia, General - DBS, MOUNJARO, AIRSUPRA, REPATHA.
Industry payments across NY — which companies pay providers there.
